Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. Coli in the rat

Thorax

Volumn 70, Issue 7, 2015, Pages 625-635

  Devaney, James ^a   Horie, Shahd ^a   Masterson, Claire ^a   Elliman, Steve ^a   Barry, Frank ^a   O'Brien, Timothy ^a   Curley, Gerard F ^b   O'Toole, Daniel ^a   Laffey, John G ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PHOSPHATE BUFFERED SALINE;

ACUTE LUNG INJURY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL LOAD; CELL PHAGOCYTOSIS; CELL TRANSPLANTATION; CELLULAR SECRETION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE DURATION; DISEASE SEVERITY; ESCHERICHIA COLI PNEUMONIA; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN MESENCHYMAL STROMAL CELL TRANSPLANTATION; IN VITRO STUDY; INTERMETHOD COMPARISON; INTRATHECAL HUMAN MESENCHYMAL STROMAL CELL TRANSPLANTATION; INTRAVENOUS HUMAN MESENCHYMAL STROMAL CELL TRANSPLANTATION; MACROPHAGE; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; ANIMAL; COMPLICATION; DISEASE MODEL; ENDOTRACHEAL INTUBATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EVALUATION STUDY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROBIOLOGY; PATHOLOGY; PHAGOCYTOSIS; PNEUMONIA, BACTERIAL; PROCEDURES; XENOGRAFT;

ACUTE LUNG INJURY; ANIMALS; BACTERIAL LOAD; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; INTUBATION, INTRATRACHEAL; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PHAGOCYTOSIS; PNEUMONIA, BACTERIAL; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84939236722     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-206813     Document Type: Article

References (36)

1. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-33.
2. Matthay M, Ware L, Zimmerman G. The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731-40.
3. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Resp Crit Care Med 1998; 157: 1159-64.
4. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000; 161: 1942-8.
5. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest 2001; 119: 1179-8.
6. Gotts J, Matthay M. Mesenchymal stem cells and acute lung injury. Crit Care Clin 2011; 27: 719-33.
7. Rossignol J, Boyer C, Thinard R, et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009; 13(8B): 2547-58.
8. Mei S, Haitsma J, Dos Santos C, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047-57.
9. Németh K, Leelahavanichkul A, Yuen P, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-9.
10. Waterman R, Tomchuck S, Henkle S, et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE 2010; 5: e10088.
11. Aguilar S, Scotton C, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 2009; 4: e8013.
12. Ortiz L, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003; 100: 8407-11.
13. Kotton D, Ma B, Cardoso W, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001; 128: 5181-8.
14. Krasnodembskaya A, Samarani G, Song Y, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 2012; 302: L1003-13.
15. Nemeth K, Mayer B, Mezey E. Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands. J Mol Med 2010; 88: 5-10.
16. Curley G, Hayes M, Ansari B, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012; 67: 496-501.
17. Curley G, Ansari B, Hayes M, et al. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 2013; 118: 924-32.
18. Mao M, Wang S, Lv X, et al. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock 2010; 34: 196-204.
19. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179: 1855-63.
20. Ionescu L, Byrne R, van Haaften T, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 2012; 303: L967-77.
21. Lee J, Krasnodembskaya A, McKenna D, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013; 187: 751-60.
22. Asmussen S, Ito H, Traber DL, et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax 2014; 69: 819-25.
23. Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 2015; 3: 24-32.
24. Hayes M, Masterson C, Devaney J, et al. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015; 122: 363-73.
25. McAuley DF, Curley GF, Hamid UI, et al. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014; 306: L809-15.
26. O'Croinin DF, Hopkins NO, Moore MM, et al. Hypercapnic acidosis does not modulate the severity of bacterial pneumonia-induced lung injury. Crit Care Med 2005; 33: 2606-12.
27. O'Croinin DF, Nichol AD, Hopkins N, et al. Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury. Crit Care Med 2008; 36: 2128-35.
28. Devaney J, Curley GF, Hayes M, et al. Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia. Crit Care 2013; 17: R82.
29. Costello J, Higgins B, Contreras M, et al. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 2009; 37: 2412-20.
30. Higgins BD, Costello J, Contreras M, et al. Differential effects of buffered hypercapnia versus hypercapnic acidosis on shock and lung injury induced by systemic sepsis. Anesthesiology 2009; 111: 1317-26.
31. Laffey JG, Honan D, Hopkins N, et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med 2004; 169: 46-56.
32. Danchuk S, Ylostalo JH, Hossain F, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011; 2: 27.
33. Gupta N, Krasnodembskaya A, Kapetanaki M, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax 2012; 67: 533-9.
34. Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229-38.
35. Weiss D, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143: 1590-8.
36. Shyamsundar M, McAuley DF, Ingram RJ, et al. Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med 2014; 189: 1520-9.